via reefs.com
Thraustochytrids can enhance the sensory properties of plant-based meats and confer a delicious taste.
A fungus-like microbe taken from the pristine waters of South Australia could prove to be a vital ingredient in making everything from nutritional supplements, medicines and biofuels to animal-free meat, according to Flinders University researchers.
“Currently, the global market for nutritional supplements is increasing in value, with more and more people turning to them for added health and diet benefits,” says Associate Professor Munish Puri, a medical biotechnology researcher in Flinders University’s College of Medicine and Public Health.
“However, our current sources of these products – namely animals including sea creatures – are not sustainable in the long run, so there is a need to search for alternative sources of protein and lipids required in their production.”
Writing in the journal Trends in Biotechnology, Associate Professor Puri and colleagues say thraustochytrids (a group of marine microbes) could prove a valuable source for not only nutritional supplements, but provide for other industries, to produce medicine, cosmetics, aquaculture, biofuels and, eventually, animal-free meat.
“By tuning the thraustochytrids through precision fermentation, we can produce single-cell oil (SCO), which can be used by the nutraceutical industry for producing supplements and other nutraceuticals, with the added advantage that it doesn’t require agricultural land and can be cultivated in a controlled environment, keeping the SCO free from contamination,” says Associate Professor Puri.
“We also know that thraustochytrids can produce a wide range of high-value bioproducts, such as omega-3 fatty acids, squalene (used in cosmetics and vaccines), exopolysaccharides (used in pharmaceuticals), enzymes, aquaculture feed, pigments and lipids suitable for biodiesel composition.”
The authors say the integration of bioprocessing, fermentation and advanced manufacturing result in economically sustainable processes that would enable industrial-scale production of these biologically important products, including the development of plant-based meats.
“To produce plant-based meats, it requires proteins, nutrients and fats. Thraustochytrids are an oleaginous (oily) microorganism that produce high lipid (fat) content and it is expected that these fats will mimic the structure of animal fats, enhancing the sensory properties of plant-based meats and confer a delicious taste,” says Associate Professor Puri.
“With the growth in popularity of vegan and vegetarian diets, alongside concerns about the sustainability of our agricultural industries and its impact on fossil fuel emissions, we can see that finding alternatives to animal products is a major growing market.”
This month, Associate Professor Puri and his team at Flinders University have endorsed a partner agreement with Nourish Ingredients Pty Ltd, to further develop animal-free meat products.
The project – Advanced lipid fermentation facility of local manufacture of future foods – has received $2.829 million via the federal government’s Cooperative Research Centres Projects (CRC-P) Grants, which support short-term multi-institutional collaborative research projects.
“We are looking to develop an algal production system that can provide a predictable and environmentally friendly alternative to animal sources and can serve growing vegetarian markets in Australia,” says Associate Professor Puri.
Original Article: Ocean organism could be key to animal-free meat
More from: Flinders University
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Thraustochytrids
- Feed has no items.
Go deeper with Google Headlines on:
Thraustochytrids
[google_news title=”” keyword=”thraustochytrids” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Nutraceuticals
- Cosmos Health Participated in Vitafoods Europe 202…
CHICAGO, IL / ACCESSWIRE / May 17, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, ...
- Hemp-Focused CV Sciences Reports Steady Q1 Revenue Amid Operational Hurdles And Acquisition Of Nutraceuticals Manufacturer
CV Sciences, Inc. (OTCQB:CVSI), a San Diego-based company specializing in hemp extracts, nutraceuticals and plant-based foods announced its financial results Tuesday for the quarter ended March 31, ...
- Nestlé India, Dr. Reddy’s form joint venture for nutraceuticals in India
The joint venture will help JV Partners grow their complementary nutraceuticals portfolios in various categories.
- Ashland to Sell its Nutraceuticals Business
Ashland has entered into a definitive agreement with Turnspire Capital Partners to sell its nutraceuticals business. The business supplies a broad portfolio of active ingredients and formulation aids ...
- Ashland (ASH) to Divest Nutraceuticals Business to Turnspire
Ashland Inc. ASH announced an agreement to sell its nutraceuticals business to Turnspire Capital Partners LLC. The deal is anticipated to close during the calendar third quarter of 2024, pending the ...
Go deeper with Google Headlines on:
Nutraceuticals
[google_news title=”” keyword=”nutraceuticals” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]